LT vs SUNPHARMA: Stock Comparison
LARSEN & TOUBRO is the larger company by market capitalisation. LARSEN & TOUBRO shows a lower P/E, a higher ROE and a higher dividend yield, while SUN PHARMACEUTICAL IND L shows faster revenue growth, lower leverage and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.
Metric snapshot
LT leads 5; SUNPHARMA leads 8 of 13
Interactive comparison
Compare the numbers that shape the decision
Every row uses its own scale. Switch lenses to compare like with like.
Valuation lens
What price are you paying?
✓ marks the usual favourable reading; it is not a recommendation.
Key Differences
Each difference is a single, relative reading — StockeZee does not name an overall winner.
Profile
| Metric | LT | SUNPHARMA |
|---|---|---|
| Sector | Construction | Healthcare |
| Industry | Civil Construction | Pharmaceuticals |
Price
| Metric | LT | SUNPHARMA |
|---|---|---|
| Live Price | ₹3,703.3 | ₹1,760 |
| Day Change | 2.16% | 0.01% |
| Volume | 13.39 L | 13.46 L |
| 52-Week High | ₹4,440 | ₹2,046.9 |
| 52-Week Low | ₹3,288.1 | ₹1,583.7 |
| Distance from 52W High | -16.59% | -14.02% |
Valuation
| Metric | LT | SUNPHARMA |
|---|---|---|
| Market Cap | ₹5.09 L Cr | ₹4.22 L Cr |
| P/E Ratio | 30.67x | 34.85x |
| P/B Ratio | 4.66x | 5.04x |
| EPS | ₹29.97 | ₹12.06 |
| Book Value | ₹934.27 | ₹349.6 |
| Dividend Yield | 1.03% | 0.91% |
Growth
| Metric | LT | SUNPHARMA |
|---|---|---|
| Revenue Growth (TTM YoY) | 11.7% | 12.8% |
| EPS Growth (TTM YoY) | -34.5% | 25.6% |
| Qtr Sales Growth | -17.91% | 4.71% |
| Qtr Profit Growth | -18.67% | 7.07% |
Profitability & Leverage
| Metric | LT | SUNPHARMA |
|---|---|---|
| ROE | 14.75% | 11.76% |
| ROCE | 9.05% | 9.6% |
| Net Margin | 6.04% | 18.56% |
| Operating Margin | 10.08% | 22.81% |
| Debt to Equity | 0.95x | 0.6x |
Shareholding
As of Jun 2026 • change vs previous quarter| Metric | LT | SUNPHARMA |
|---|---|---|
| Promoter Holding | — | 54.48% |
| FII Holding | 19.13%▲ 0.35 pp | 14.53%▼ 1.4 pp |
| DII Holding | 43.02%▼ 0.31 pp | 22.18%▲ 1.07 pp |
| Public Holding | 37.6%▼ 0.04 pp | 8.81%▲ 0.33 pp |
How to Read This Comparison
Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.
Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: LARSEN & TOUBRO and SUN PHARMACEUTICAL IND L.
Related Comparisons
Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.